A citation-based method for searching scientific literature

Belinda Vicuña, Harold D Delaney, Kristina G Flores, Lori Ballinger, Melanie Royce, Zoneddy Dayao, Tuya Pal, Anita Y Kinney. J Community Genet 2018
Times Cited: 8







List of co-cited articles
18 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


American Society of Clinical Oncology Policy Statement Update: Genetic and Genomic Testing for Cancer Susceptibility.
Mark E Robson, Angela R Bradbury, Banu Arun, Susan M Domchek, James M Ford, Heather L Hampel, Stephen M Lipkin, Sapna Syngal, Dana S Wollins, Noralane M Lindor. J Clin Oncol 2015
304
37

The Changing Landscape of Genetic Testing for Inherited Breast Cancer Predisposition.
Anosheh Afghahi, Allison W Kurian. Curr Treat Options Oncol 2017
18
25

Availability and payer coverage of BRCA1/2 tests and gene panels.
Elizabeth Clain, Julia R Trosman, Michael P Douglas, Christine B Weldon, Kathryn A Phillips. Nat Biotechnol 2015
18
25

Factors Associated with Interest in Gene-Panel Testing and Risk Communication Preferences in Women from BRCA1/2 Negative Families.
Kristina G Flores, Laurie E Steffen, Christopher J McLouth, Belinda E Vicuña, Amanda Gammon, Wendy Kohlmann, Lucretia Vigil, Zoneddy R Dayao, Melanie E Royce, Anita Y Kinney. J Genet Couns 2017
8
25

Challenges to clinical utilization of hereditary cancer gene panel testing: perspectives from the front lines.
Rebecca K Marcus, Jennifer L Geurts, Jessica A Grzybowski, Kiran K Turaga, T Clark Gamblin, Kimberly A Strong, Fabian M Johnston. Fam Cancer 2015
8
25

Clinical Application of Multigene Panels: Challenges of Next-Generation Counseling and Cancer Risk Management.
Thomas Paul Slavin, Mariana Niell-Swiller, Ilana Solomon, Bita Nehoray, Christina Rybak, Kathleen R Blazer, Jeffrey N Weitzel. Front Oncol 2015
68
25

Clinical Actionability of Multigene Panel Testing for Hereditary Breast and Ovarian Cancer Risk Assessment.
Andrea Desmond, Allison W Kurian, Michele Gabree, Meredith A Mills, Michael J Anderson, Yuya Kobayashi, Nora Horick, Shan Yang, Kristen M Shannon, Nadine Tung,[...]. JAMA Oncol 2015
202
25

Impact of Panel Gene Testing for Hereditary Breast and Ovarian Cancer on Patients.
Heidi S Lumish, Hallie Steinfeld, Carrie Koval, Donna Russo, Elana Levinson, Julia Wynn, James Duong, Wendy K Chung. J Genet Couns 2017
61
25

Patient feedback and early outcome data with a novel tiered-binned model for multiplex breast cancer susceptibility testing.
Angela R Bradbury, Linda J Patrick-Miller, Brian L Egleston, Laura DiGiovanni, Jamie Brower, Diana Harris, Evelyn M Stevens, Kara N Maxwell, Abha Kulkarni, Tyler Chavez,[...]. Genet Med 2016
43
25

Development of a tiered and binned genetic counseling model for informed consent in the era of multiplex testing for cancer susceptibility.
Angela R Bradbury, Linda Patrick-Miller, Jessica Long, Jacquelyn Powers, Jill Stopfer, Andrea Forman, Christina Rybak, Kristin Mattie, Amanda Brandt, Rachelle Chambers,[...]. Genet Med 2015
53
25

Disparities in genetic testing: thinking outside the BRCA box.
Michael J Hall, Olufunmilayo I Olopade. J Clin Oncol 2006
117
25

Multigene Panel Testing in Oncology Practice: How Should We Respond?
Allison W Kurian, James M Ford. JAMA Oncol 2015
44
25

Randomized Noninferiority Trial of Telephone vs In-Person Disclosure of Germline Cancer Genetic Test Results.
Angela R Bradbury, Linda J Patrick-Miller, Brian L Egleston, Michael J Hall, Susan M Domchek, Mary B Daly, Pamela Ganschow, Generosa Grana, Olufunmilayo I Olopade, Dominique Fetzer,[...]. J Natl Cancer Inst 2018
22
25

Large, Prospective Analysis of the Reasons Patients Do Not Pursue BRCA Genetic Testing Following Genetic Counseling.
Sommer Hayden, Sarah Mange, Debra Duquette, Nancie Petrucelli, Victoria M Raymond. J Genet Couns 2017
22
25

Uptake, Results, and Outcomes of Germline Multiple-Gene Sequencing After Diagnosis of Breast Cancer.
Allison W Kurian, Kevin C Ward, Ann S Hamilton, Dennis M Deapen, Paul Abrahamse, Irina Bondarenko, Yun Li, Sarah T Hawley, Monica Morrow, Reshma Jagsi,[...]. JAMA Oncol 2018
69
25

Awareness, knowledge, perceptions, and attitudes towards genetic testing for cancer risk among ethnic minority groups: a systematic review.
Katie E J Hann, Madeleine Freeman, Lindsay Fraser, Jo Waller, Saskia C Sanderson, Belinda Rahman, Lucy Side, Sue Gessler, Anne Lanceley. BMC Public Health 2017
83
25

Prevalence and Spectrum of Germline Cancer Susceptibility Gene Mutations Among Patients With Early-Onset Colorectal Cancer.
Rachel Pearlman, Wendy L Frankel, Benjamin Swanson, Weiqiang Zhao, Ahmet Yilmaz, Kristin Miller, Jason Bacher, Christopher Bigley, Lori Nelsen, Paul J Goodfellow,[...]. JAMA Oncol 2017
269
25

A high frequency of BRCA mutations in young black women with breast cancer residing in Florida.
Tuya Pal, Devon Bonner, Deborah Cragun, Alvaro N A Monteiro, Catherine Phelan, Lily Servais, Jongphil Kim, Steven A Narod, Mohammad R Akbari, Susan T Vadaparampil. Cancer 2015
51
25

Economic analysis of rapid and sensitive polymerase chain reaction testing in the emergency department for influenza infections in children.
Richard E Nelson, Chris Stockmann, Adam L Hersh, Andrew T Pavia, Kent Korgenksi, Judy A Daly, Marc R Couturier, Krow Ampofo, Emily A Thorell, Elizabeth H Doby,[...]. Pediatr Infect Dis J 2015
46
12


Multigene Panel Testing Detects Equal Rates of Pathogenic BRCA1/2 Mutations and has a Higher Diagnostic Yield Compared to Limited BRCA1/2 Analysis Alone in Patients at Risk for Hereditary Breast Cancer.
Nimmi S Kapoor, Lisa D Curcio, Carlee A Blakemore, Amy K Bremner, Rachel E McFarland, John G West, Kimberly C Banks. Ann Surg Oncol 2015
69
12

Preoperative Panel Testing for Hereditary Cancer Syndromes Does Not Significantly Impact Time to Surgery for Newly Diagnosed Breast Cancer Patients Compared with BRCA1/2 Testing.
Amy E Murphy, Lala Hussain, Ching Ho, Erik Dunki-Jacobs, David Lee, Ashley Tameron, Karen Huelsman, Courtney Rice, Barbara A Wexelman. Ann Surg Oncol 2017
4
25


Routine use of gene panel testing in hereditary breast cancer should be performed with caution.
Cedric van Marcke, Anne De Leener, Martine Berlière, Miikka Vikkula, Francois P Duhoux. Crit Rev Oncol Hematol 2016
14
12

Implementing Pharmacogenomics in Europe: Design and Implementation Strategy of the Ubiquitous Pharmacogenomics Consortium.
C H van der Wouden, A Cambon-Thomsen, E Cecchin, K C Cheung, C L Dávila-Fajardo, V H Deneer, V Dolžan, M Ingelman-Sundberg, S Jönsson, M O Karlsson,[...]. Clin Pharmacol Ther 2017
130
12

Implementing personalized medicine: development of a cost-effective customized pharmacogenetics genotyping array.
J A Johnson, B M Burkley, T Y Langaee, M J Clare-Salzler, T E Klein, R B Altman. Clin Pharmacol Ther 2012
74
12

Gene panel testing for inherited cancer risk.
Michael J Hall, Andrea D Forman, Robert Pilarski, Georgia Wiesner, Veda N Giri. J Natl Compr Canc Netw 2014
78
12

DMET microarray technology for pharmacogenomics-based personalized medicine.
James K Burmester, Marina Sedova, Michael H Shapero, Elaine Mansfield. Methods Mol Biol 2010
57
12

Cancer genetic testing panels for inherited cancer susceptibility: the clinical experience of a large adult genetics practice.
Christina G Selkirk, Kristen J Vogel, Anna C Newlin, Scott M Weissman, Shelly M Weiss, Chi-Hsiung Wang, Peter J Hulick. Fam Cancer 2014
26
12

Evaluation of laboratory perspectives on hereditary cancer panels.
Jessica Stoll, Scott M Weissman, Nicole Hook, Christina Selkirk, Amy Knight Johnson, Anna Newlin, Kristen J Vogel Postula. Fam Cancer 2016
3
33

Payer Coverage for Hereditary Cancer Panels: Barriers, Opportunities, and Implications for the Precision Medicine Initiative.
Julia R Trosman, Christine B Weldon, Michael P Douglas, Allison W Kurian, R Kate Kelley, Patricia A Deverka, Kathryn A Phillips. J Natl Compr Canc Netw 2017
23
12

Pharmacogenomics Implementation: Considerations for Selecting a Reference Laboratory.
Teresa T Vo, Gillian C Bell, Aniwaa Owusu Obeng, J Kevin Hicks, Henry M Dunnenberger. Pharmacotherapy 2017
17
12

Development and analytical validation of a 25-gene next generation sequencing panel that includes the BRCA1 and BRCA2 genes to assess hereditary cancer risk.
Thaddeus Judkins, Benoît Leclair, Karla Bowles, Natalia Gutin, Jeff Trost, James McCulloch, Satish Bhatnagar, Adam Murray, Jonathan Craft, Bryan Wardell,[...]. BMC Cancer 2015
71
12


The clinical validity and utility of combinatorial pharmacogenomics: Enhancing patient outcomes.
Joachim Benitez, Michael R Jablonski, Josiah D Allen, Joel G Winner. Appl Transl Genom 2015
13
12

Pharmacogenomics and individualized medicine: translating science into practice.
K R Crews, J K Hicks, C-H Pui, M V Relling, W E Evans. Clin Pharmacol Ther 2012
138
12

The Pharmacogenomics Research Network Translational Pharmacogenetics Program: Outcomes and Metrics of Pharmacogenetic Implementations Across Diverse Healthcare Systems.
J A Luzum, R E Pakyz, A R Elsey, C E Haidar, J F Peterson, M Whirl-Carrillo, S K Handelman, K Palmer, J M Pulley, M Beller,[...]. Clin Pharmacol Ther 2017
78
12

Genetic variation among 82 pharmacogenes: The PGRNseq data from the eMERGE network.
W S Bush, D R Crosslin, A Owusu-Obeng, J Wallace, B Almoguera, M A Basford, S J Bielinski, D S Carrell, J J Connolly, D Crawford,[...]. Clin Pharmacol Ther 2016
95
12

Application of Panel-Based Tests for Inherited Risk of Cancer.
Payal D Shah, Katherine L Nathanson. Annu Rev Genomics Hum Genet 2017
21
12

Clinical utility of a 377 gene custom next-generation sequencing epilepsy panel.
Jen Bevilacqua, Andrew Hesse, Brian Cormier, Jennifer Davey, Devanshi Patel, Kritika Shankar, Honey V Reddi. J Genet 2017
7
14

A randomized trial of genotype-guided dosing of warfarin.
Munir Pirmohamed, Girvan Burnside, Niclas Eriksson, Andrea L Jorgensen, Cheng Hock Toh, Toby Nicholson, Patrick Kesteven, Christina Christersson, Bengt Wahlström, Christina Stafberg,[...]. N Engl J Med 2013
541
12

Utility and limitations of exome sequencing in the molecular diagnosis of pediatric inherited platelet disorders.
Edward J Romasko, Batsal Devkota, Sawona Biswas, Vijayakumar Jayaraman, Ramakrishnan Rajagopalan, Matthew C Dulik, Christopher S Thom, Jiwon Choi, Sowmya Jairam, Maria I Scarano,[...]. Am J Hematol 2018
16
12



Gene-panel sequencing and the prediction of breast-cancer risk.
Douglas F Easton, Paul D P Pharoah, Antonis C Antoniou, Marc Tischkowitz, Sean V Tavtigian, Katherine L Nathanson, Peter Devilee, Alfons Meindl, Fergus J Couch, Melissa Southey,[...]. N Engl J Med 2015
495
12

The emerging era of pharmacogenomics: current successes, future potential, and challenges.
J W Lee, F Aminkeng, A P Bhavsar, K Shaw, B C Carleton, M R Hayden, C J D Ross. Clin Genet 2014
43
12

A Systematic Comparison of Traditional and Multigene Panel Testing for Hereditary Breast and Ovarian Cancer Genes in More Than 1000 Patients.
Stephen E Lincoln, Yuya Kobayashi, Michael J Anderson, Shan Yang, Andrea J Desmond, Meredith A Mills, Geoffrey B Nilsen, Kevin B Jacobs, Federico A Monzon, Allison W Kurian,[...]. J Mol Diagn 2015
113
12

EXAMINING EVIDENCE IN U.S. PAYER COVERAGE POLICIES FOR MULTI-GENE PANELS AND SEQUENCING TESTS.
James D Chambers, Cayla J Saret, Jordan E Anderson, Patricia A Deverka, Michael P Douglas, Kathryn A Phillips. Int J Technol Assess Health Care 2017
15
12

Review of Commercially Available Epilepsy Genetic Panels.
Chelsea Chambers, Laura A Jansen, Radhika Dhamija. J Genet Couns 2016
34
12

Expanded Gene Panel Use for Women With Breast Cancer: Identification and Intervention Beyond Breast Cancer Risk.
Erin O'Leary, Daniela Iacoboni, Jennifer Holle, Scott T Michalski, Edward D Esplin, Shan Yang, Karen Ouyang. Ann Surg Oncol 2017
28
12


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.